KLINIQ Stock Overview
Provides skin medical treatment services under the Klinique brand name in Thailand.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
The Klinique Medical Clinic Public Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ฿42.75 |
| 52 Week High | ฿45.25 |
| 52 Week Low | ฿34.00 |
| Beta | 0 |
| 1 Month Change | 13.25% |
| 3 Month Change | 10.32% |
| 1 Year Change | 11.04% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 3.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| KLINIQ | TH Healthcare | TH Market | |
|---|---|---|---|
| 7D | 1.8% | -3.0% | -1.2% |
| 1Y | 11.0% | -6.1% | -11.2% |
Return vs Industry: KLINIQ exceeded the TH Healthcare industry which returned -6.1% over the past year.
Return vs Market: KLINIQ exceeded the TH Market which returned -11.2% over the past year.
Price Volatility
| KLINIQ volatility | |
|---|---|
| KLINIQ Average Weekly Movement | 3.7% |
| Healthcare Industry Average Movement | 3.4% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in TH Market | 8.9% |
| 10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: KLINIQ has not had significant price volatility in the past 3 months.
Volatility Over Time: KLINIQ's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Apiruj Thongwattana | www.theklinique.com |
The Klinique Medical Clinic Public Company Limited provides skin medical treatment services under the Klinique brand name in Thailand. Its services include face lift, acne and acne scars, skin tightening, filler, fat dissolving injection, laser hair removal, skin treatment, skin injection, Mesoface, and Mesotua, as well as nose, eye, and facial surgery. The company sells cosmetics and cosmeceutical products.
The Klinique Medical Clinic Public Company Limited Fundamentals Summary
| KLINIQ fundamental statistics | |
|---|---|
| Market cap | ฿9.41b |
| Earnings (TTM) | ฿294.83m |
| Revenue (TTM) | ฿2.46b |
31.9x
P/E Ratio3.8x
P/S RatioIs KLINIQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KLINIQ income statement (TTM) | |
|---|---|
| Revenue | ฿2.46b |
| Cost of Revenue | ฿1.16b |
| Gross Profit | ฿1.30b |
| Other Expenses | ฿1.01b |
| Earnings | ฿294.83m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.34 |
| Gross Margin | 52.88% |
| Net Profit Margin | 11.97% |
| Debt/Equity Ratio | 0% |
How did KLINIQ perform over the long term?
See historical performance and comparison